Ti preghiamo di attendere, stiamo caricando i dati del grafico
Moderna Inc Community
About Moderna Inc
What is Moderna Inc?
Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its covid vaccine, which was authorized in the United States in December 2020. Moderna had 35 mRNA development candidates in clinical studies as of August 2025. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.
The current price of Moderna Inc in the market is 47,05 €, with a 24-hour trading volume of 526,52M €. The asset's market cap is 18,58B €, after moving -2.43% in the last day.
Tokenized Moderna Inc is trading at 47,02 €, with a tokenized market cap of 204,34K € and a 24-hour trading volume of 0 €. The tokenized asset has moved 0.00% in the past 24 hours.